Skip to main content
← Companies
IMCR

Immunocore Holdings plc

Data as of Oct 10, 2026
IMCR
CIK 1671927

Lobbying

$0 in reported federal lobbying spend across 7 quarterly filings, most recently Jul 17, 2026. Amounts are the sums companies and their registrants report on Lobbying Disclosure Act filings; a filing that covers several issues counts its full amount under each.

Latest filings, Apr 2025 onward

FiledRegistrant and subjectAmount
Jul 17, 2026
DLA PIPER LLP (US) for IMMUNOCORE LLC
Unspecified
$0
Apr 20, 2026
DLA PIPER LLP (US) for IMMUNOCORE LLC
Unspecified
$0
Jan 16, 2026
DLA PIPER LLP (US) for IMMUNOCORE LLC
Unspecified
$0
Oct 16, 2025
DLA PIPER LLP (US) for IMMUNOCORE LLC
Unspecified
$0
Jul 21, 2025
DLA PIPER LLP (US) for IMMUNOCORE LLC
Unspecified
$0
Apr 21, 2025
DLA PIPER LLP (US) for IMMUNOCORE LLC
Unspecified
$0

Data: FEC (PAC contributions, Schedule A), Quiver Quantitative (congressional holdings, lobbying, contracts), Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to Immunocore Holdings plc through its SEC registration (CIK 1671927) and tickers IMCR.

As of: lobbying filings through Jul 17, 2026; contract actions through Apr 15, 2025. Snapshot rebuilt Oct 10, 2026.

Holdings values are estimates from disclosed ranges. PAC contributions cover the current and previous election cycle and count only gifts to sitting members' principal campaign committees, so leadership PACs and losing candidates are not included.